These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 16115743

  • 1. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D, Beech J, Cribb A.
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [Abstract] [Full Text] [Related]

  • 2. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J, Boston R, Lindborg S, Russell GE.
    J Am Vet Med Assoc; 2007 Aug 01; 231(3):417-26. PubMed ID: 17669045
    [Abstract] [Full Text] [Related]

  • 3. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
    Beech J, McFarlane D, Lindborg S, Sojka JE, Boston RC.
    J Am Vet Med Assoc; 2011 May 15; 238(10):1305-15. PubMed ID: 21568777
    [Abstract] [Full Text] [Related]

  • 4. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J, Balm PH, Ruane NM, Pérez-Sánchez J, Wendelaar-Bonga SE, Tort L.
    Gen Comp Endocrinol; 2000 Aug 15; 119(2):152-63. PubMed ID: 10936035
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
    Beech J, Boston RC, McFarlane D, Lindborg S.
    J Am Vet Med Assoc; 2009 Sep 15; 235(6):715-22. PubMed ID: 19751169
    [Abstract] [Full Text] [Related]

  • 6. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
    Beech J, Boston R, Lindborg S.
    J Vet Intern Med; 2011 Sep 15; 25(6):1431-8. PubMed ID: 22092639
    [Abstract] [Full Text] [Related]

  • 7. Expression of three proopiomelanocortin subtype genes and mass spectrometric identification of POMC-derived peptides in pars distalis and pars intermedia of barfin flounder pituitary.
    Takahashi A, Amano M, Amiya N, Yamanome T, Yamamori K, Kawauchi H.
    Gen Comp Endocrinol; 2006 Feb 15; 145(3):280-6. PubMed ID: 16242690
    [Abstract] [Full Text] [Related]

  • 8. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses.
    Funk RA, Stewart AJ, Wooldridge AA, Kwessi E, Kemppainen RJ, Behrend EN, Zhong Q, Johnson AK.
    J Vet Intern Med; 2011 Feb 15; 25(3):579-85. PubMed ID: 21457320
    [Abstract] [Full Text] [Related]

  • 9. Circadian and circannual rhythms of cortisol, ACTH, and α-melanocyte-stimulating hormone in healthy horses.
    Cordero M, Brorsen BW, McFarlane D.
    Domest Anim Endocrinol; 2012 Nov 15; 43(4):317-24. PubMed ID: 22717182
    [Abstract] [Full Text] [Related]

  • 10. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
    Willemse T, Mol JA.
    Am J Vet Res; 1994 Dec 15; 55(12):1677-81. PubMed ID: 7887510
    [Abstract] [Full Text] [Related]

  • 11. Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction.
    Carmalt JL, Mortazavi S, McOnie RC, Allen AL, Unniappan S.
    PLoS One; 2018 Dec 15; 13(1):e0190796. PubMed ID: 29309431
    [Abstract] [Full Text] [Related]

  • 12. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
    Miller MA, Pardo ID, Jackson LP, Moore GE, Sojka JE.
    Vet Pathol; 2008 Jan 15; 45(1):26-38. PubMed ID: 18192571
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
    Dybdal NO, Hargreaves KM, Madigan JE, Gribble DH, Kennedy PC, Stabenfeldt GH.
    J Am Vet Med Assoc; 1994 Feb 15; 204(4):627-32. PubMed ID: 8163420
    [Abstract] [Full Text] [Related]

  • 14. Pituitary and interrenal function in gilthead sea bream (Sparus aurata L., Teleostei) after handling and confinement stress.
    Rotllant J, Balm PH, Pérez-Sánchez J, Wendelaar-Bonga SE, Tort L.
    Gen Comp Endocrinol; 2001 Mar 15; 121(3):333-42. PubMed ID: 11254375
    [Abstract] [Full Text] [Related]

  • 15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Orth DN, Peterson ME, Drucker WD.
    Endocrinology; 1988 Apr 15; 122(4):1250-62. PubMed ID: 3126032
    [Abstract] [Full Text] [Related]

  • 16. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
    Wilson MG, Nicholson WE, Holscher MA, Sherrell BJ, Mount CD, Orth DN.
    Endocrinology; 1982 Mar 15; 110(3):941-54. PubMed ID: 6276164
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of seasonal influences on adrenocorticotropic hormone response to the thyrotropin-releasing hormone stimulation test and its accuracy for diagnosis of pituitary pars intermedia dysfunction.
    Adams AA, Siard-Altman MH, Reedy SE, Barker D, Elzinga S, Sanz MG, Urschel K, Ireland JL.
    Vet J; 2023 Mar 15; 300-302():106035. PubMed ID: 37802466
    [Abstract] [Full Text] [Related]

  • 18. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.
    McFarlane D, Cribb AE.
    Am J Vet Res; 2005 Dec 15; 66(12):2065-72. PubMed ID: 16379648
    [Abstract] [Full Text] [Related]

  • 19. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
    Eiler H, Oliver JW, Andrews FM, Fecteau KA, Green EM, McCracken M.
    J Am Vet Med Assoc; 1997 Jul 01; 211(1):79-81. PubMed ID: 9215417
    [Abstract] [Full Text] [Related]

  • 20. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
    Hu K, Stewart AJ, Yuen KY, Hinrichsen S, Dryburgh EL, Bertin FR.
    J Vet Intern Med; 2020 May 01; 34(3):1350-1356. PubMed ID: 32255541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.